Novavax Inc.
Gaithersburg, MD Doing business as Novavax Corporate
- UEI
- ZXHWXURNS6W8
- CAGE
- 1UCZ4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 21 Firstfield Rd, Gaithersburg, MD 20878, USA
- Website
- novavax.com
- Founded
- 1987
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Vaccine development and production | ACC Aberdeen Proving Ground | $36,042,001 | |
| Division: chemical & biological PPA: chemical & biological thrust: agriculture program: foreign animal diseases (FAD)… | Office of Procurement Operations | $1,108,155 | |
| Biomedical (advanced) | Office of the Assistant Secretary for Preparedness and Response | $121,393,966 | |
| Development of a virus-like particle (VLP) vaccine for RSV | National Institutes of Health | $246,812 | |
| Manufacture & production of e selectin. | National Institutes of Health | $333,038 |
About Novavax Inc.
Novavax Inc. Corporate Division (Novavax) is a biotechnology company that develops and produces recombinant protein nanoparticle vaccines to address infectious diseases. Through past federal contracts, Novavax has provided COVID-19 vaccine research, development, and manufacturing services.
As a prime contractor, Novavax received a $45.7 million definitive contract from the Department of the Army's Aberdeen Proving Ground Contracting Command to support vaccine development and production related to the COVID-19 response. Under this contract running through December 2022, Novavax is delivering products and services out of its Maryland facility to aid Army medical research programs. Additionally, Novavax has served as a subcontractor to Armorworks Enterprises, Inc. on contracts for machined metal parts.
Novavax holds several federal Indefinite Delivery Vehicle (IDV) contracts to supply COVID-19 vaccines. This includes a $174 million IDV from the Centers for Disease Control and Prevention (CDC) to provide adult vaccines, and a separate $116 million IDV to supply pediatric vaccines if regulatory approval is obtained. Novavax also has a $800,000 Federal Supply Schedule contract with Veterans Affairs to furnish pharmaceuticals and hematology products through July 2028. Task orders under these IDVs are competed between multiple awardees.
Contract vehicles
Quick answers
What is Novavax Inc.'s UEI?
Novavax Inc.'s Unique Entity ID (UEI) in SAM.gov is ZXHWXURNS6W8.
What is Novavax Inc.'s CAGE code?
Novavax Inc.'s CAGE code is 1UCZ4.
What is Novavax Inc.'s primary NAICS code?
Novavax Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Novavax Inc. located?
Novavax Inc.'s physical address in SAM.gov is 21 Firstfield Rd, Gaithersburg, MD 20878, USA.
Is Novavax Inc. registered in SAM.gov?
Yes. Novavax Inc.'s SAM.gov registration is active through August 3, 2027.
Which contract vehicles does Novavax Inc. hold?
Novavax Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Novavax Inc.'s most recent federal award?
Novavax Inc.'s most recent federal contract award is Vaccine development and production (W911QY20C0077), from ACC Aberdeen Proving Ground, on June 4, 2020.
On GovTribe
See Novavax Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors